AI Activity Study in Patients With Elevated Blood Pressure
Applying Artificial Intelligence to a Physical Activity Intervention in Patients With Elevated Blood Pressure- a Pilot Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Yoshimi Fukuoka, PhD, RN, FAAN
- Phone Number: 415-476-8419
- Email: AIActivity.Study@ucsf.edu
Study Contact Backup
- Name: Kiley Charbonneau
- Phone Number: 415-514-0962
- Email: AIActivity.Study@ucsf.edu
Study Locations
-
-
California
-
San Francisco, California, United States, 94118
- University of California San Francisco
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age ≥18 years
- systolic blood pressure between 130 mmHg to 180 mmHg or/and diastolic blood *pressure between 80 to 100 mmHg in a research office
- speaking and reading English
- being physically inactive at work or during leisure time and willing to be physically active
- having an iPhone 8 or newer or an Android Lollipop or newer
Exclusion Criteria:
- self-reported diagnosis of coronary heart disease, medical condition or other physical problem necessitating special attention in an exercise program (e.g., cancer, eating disorder, uncontrolled diabetes)
- current participation in a lifestyle modification program or research study
- self-report of being currently pregnant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Artificial Intelligence (AI) Activity group
Participants in this group receive an AI based intervention (automated and personalized daily step goal intervention involving a sophisticated activity analytics algorithm using advanced statistics and machine learning and message)
|
The intervention provides participants with an automated and personalized daily step goal intervention involving a sophisticated activity analytics algorithm using advanced statistics and machine learning.
|
|
Active Comparator: Control group
Participants in this group receive a standardized and fixed 10,000 daily steps goal intervention.
|
The intervention provides participants with an automated daily 10,000 step goal intervention
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in weekly daily average steps
Time Frame: Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
measured by ActiGraph GT9X Link]
|
Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
|
Duration (minutes) of moderate to vigorous intensity physical activity (MVPA) per day
Time Frame: Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
measured by ActiGraph GT9X Link]
|
Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Systolic blood pressure (SBP)
Time Frame: Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
|
|
Changes in diastolic blood pressure (DBP)
Time Frame: Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
|
|
aortic stiffness
Time Frame: Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
measured by SphigmoCor XCEL system
|
Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
|
sodium intake
Time Frame: Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
as measured in 24-hour urine samples
|
Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
|
Changes in weight
Time Frame: Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
|
|
Changes in Body Mass Index (BMI)
Time Frame: Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
using weight and height to calculate
|
Baseline (run-in period), 4 week-test period, and 3-month intervention period
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Yoshimi Fukuoka, PhD, RN, FAAN, University of California, San Francisco
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 18-26452
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.